Suppr超能文献

CD44 和 AREG 在 HPV 和 HPV 鳞状细胞癌中经选择性酪氨酸激酶抑制剂治疗后的表达模式。

Expression Patterns of CD44 and AREG Under Treatment With Selective Tyrosine Kinase Inhibitors in HPV and HPV Squamous Cell Carcinoma.

机构信息

Department of Otorhinolaryngology Head and Neck Surgery, University Hospital Essen, University Duisburg-Essen, Essen, Germany

Department of Otorhinolaryngology Head and Neck Surgery, University Hospital Mannheim, Medical Faculty Mannheim, University Heidelberg, Mannheim, Germany.

出版信息

Cancer Genomics Proteomics. 2020 Sep-Oct;17(5):579-585. doi: 10.21873/cgp.20214.

Abstract

BACKGROUND

We investigated the expression patterns of cluster of differentiation (CD) 44 and amphiregulin (AREG), two signaling molecules essential for cell proliferation and differentiation, under the influence of selective tyrosine kinase inhibitors (TKIs) in human papillomavirus (HPV) and HPV squamous carcinoma cell lines.

MATERIALS AND METHODS

The protein expression of CD44 and AREG was determined by sandwich enzyme-linked immunosorbent assay in HPV cell lines UMSCC-11A and UMSCC-14C, and HPV CERV-196 cells after TKI treatment.

RESULTS

The expression of AREG and CD44 was dependent on the cell line's HPV status. AREG expression increased after incubation with nilotinib in HPV tumor cells. The expression of CD44 was significantly influenced by all drugs; its expression under selective epidermal growth factor receptor inhibition was mostly reduced, whereas nilotinib led to an exceptional increase of CD44 expression.

CONCLUSION

The selective drug treatment options significantly influenced the expression of CD44 and AREG in HPV and HPV tumor cells, constituting the need for personalized treatment options.

摘要

背景

我们研究了细胞分化(CD)44 和 Amphiregulin(AREG)这两种信号分子在人乳头瘤病毒(HPV)和 HPV 鳞状癌细胞系中受选择性酪氨酸激酶抑制剂(TKI)影响的表达模式。

材料和方法

采用夹心酶联免疫吸附试验检测 HPV 细胞系 UMSCC-11A 和 UMSCC-14C 以及 HPV CERV-196 细胞在 TKI 处理后的 CD44 和 AREG 蛋白表达。

结果

AREG 和 CD44 的表达取决于细胞系的 HPV 状态。在 HPV 肿瘤细胞中用尼罗替尼孵育后 AREG 表达增加。CD44 的表达受所有药物的显著影响;表皮生长因子受体选择性抑制下的 CD44 表达大多降低,而尼罗替尼导致 CD44 表达异常增加。

结论

选择性药物治疗方案显著影响 HPV 和 HPV 肿瘤细胞中 CD44 和 AREG 的表达,这构成了个性化治疗方案的需求。

相似文献

5
Hyaluronan-CD44 interaction promotes HPV 16 E6 oncogene-mediated oropharyngeal cell carcinoma survival and chemoresistance.
Matrix Biol. 2019 May;78-79:180-200. doi: 10.1016/j.matbio.2018.07.008. Epub 2018 Aug 3.

引用本文的文献

2
NGF Signaling Interacts With the Hippo/YAP Pathway to Regulate Cervical Cancer Progression.
Front Oncol. 2021 Oct 14;11:688794. doi: 10.3389/fonc.2021.688794. eCollection 2021.

本文引用的文献

1
Inhibition of CD44 sensitizes cisplatin-resistance and affects Wnt/β-catenin signaling in HNSCC cells.
Int J Biol Macromol. 2020 Apr 15;149:501-512. doi: 10.1016/j.ijbiomac.2020.01.131. Epub 2020 Jan 15.
2
Pharmacokinetics of Dasatinib.
Prague Med Rep. 2019;120(2-3):52-63. doi: 10.14712/23362936.2019.10.
3
Monitoring Src status after dasatinib treatment in HER2+ breast cancer with Zr-trastuzumab PET imaging.
Breast Cancer Res. 2018 Oct 25;20(1):130. doi: 10.1186/s13058-018-1055-2.
5
Clinical Pharmacokinetic and Pharmacodynamic Overview of Nilotinib, a Selective Tyrosine Kinase Inhibitor.
J Clin Pharmacol. 2018 Dec;58(12):1533-1540. doi: 10.1002/jcph.1312. Epub 2018 Sep 4.
6
Trends in Human Papillomavirus-Associated Cancers - United States, 1999-2015.
MMWR Morb Mortal Wkly Rep. 2018 Aug 24;67(33):918-924. doi: 10.15585/mmwr.mm6733a2.
8
9
Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer.
Clin Cancer Res. 2018 Jun 15;24(12):2828-2843. doi: 10.1158/1078-0432.CCR-17-1339. Epub 2018 Mar 29.
10
Differential recruitment of CD44 isoforms by ErbB ligands reveals an involvement of CD44 in breast cancer.
Oncogene. 2018 Mar;37(11):1472-1484. doi: 10.1038/s41388-017-0030-1. Epub 2018 Jan 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验